Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors

Clinical trial NCT00075439 · COMPLETED

Trial details

NCT number: NCT00075439
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Gastrinoma Glucagonoma Insulinoma Metastatic Gastrointestinal Carcinoid Tumor Pancreatic Polypeptide Tumor Recurrent Gastrointestinal Carcinoid Tumor Recurrent Islet Cell Carcinoma Somatostatinoma WDHA Syndrome

Start date: 2003-12-01
Primary completion: 2007-05-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.